Table 1.

Comparison of ceftriaxone, and carbapenem groups

Characteristics of the cases	Carbapenem group (n=18)	Ceftriaxone group (n=47)	p
Age Mean SD (year)	74.5±12.0	71.9±14.7	0.607
Gender, n (%)
Female, n (%)	8 (44.4)	22 (46.8)	0.864
Male, n (%)	10 (55.6)	25 (53.2)
Admission complaints, n (%)
Fever, n (%)	15 (83.3)	41 (87.2)	0.699
Confusion, n (%)	6 (33.3)	14 (29.8)	0.782
Dysuria, n (%)	7 (38.9)	14 (29.8)	0.782
Flank pain, n (%)	3 (16.7)	11 (23.4)	0.740
Vomiting, n (%)	4 (22.2)	18 (28.3)	0.220
History
Hospitalization within the last 3 months, n (%)	9 (50.0)	12 (25.5)	0.059
Antibiotic use within the last 10 days, n (%)	5 (27.8)	9 (19.1)	0.507
Physical examination
Tachycardia (HR>100 bpm), n (%)	8 (44.4)	18 (38.4)	0.651
Tachypnea (>24/min), n (%)	7 (38.9)	12 (25.5)	0.289
Hypotension (SBP<90), n (%)	0 (0)	5 (10.6)	0.311
Costovertebral angle tenderness, n (%)	8 (44.4)	15 (31.9)	0.344
Suprapubic tenderness, n (%)	0 (0)	5 (10.6)	0.311
Complicating factors
Urolithiasis, n (%)	0 (0)	6 (12.8)	0.175
Urinary system malignancy, n (%)	1 (5.6)	3 (6.4)	1.000
Benign prostatic hyperplasia, n (%)	1 (5.6)	4 (8.5)	1.000
Nephrostomy, n (%)	1 (5.6)	1 (2.1)	0.480
Neurogenic bladder, n (%)	0 (0)	2 (4.3)	1.000
Indwelling urinary catheterization, n (%)	0 (0)	1 (2.1)	1.000
Intermittent catheterization, n (%)	0 (0)	1 (2.1)	1.000
Diabetes mellitus, n (%)	4 (2.2)	14 (29.8)	0.758
Laboratory parametres
Pyuria, n (%)	18 (100)	44 (93.6)	0.555
Leucocytes, median	15.977.20	14.454.40	0.525
Neutrophils, median	13.696.10	12.523.80	0.758
Platelets, median	218444.4	217297.9	0.964
Hemoglobin, median	11.8	11.1	0.211
CRP, median	180.4	215.4	0.195
Hospital stay (days) Mean±SD	11.1±6.1	10.0±5.3	0.586
Health state at discharge n (%)
Cure	17 (94.4)	43 (91.5)	1.000
Referral to ICU	0 (0)	2 (4.3)
Death	1 (5.6)	2 (4.3)

SD: standard deviation; SBP: Systolic blood pressure; CRP: C-reactive protein; ICU: intensive care unit